CARE
Overvalued by 53.6% based on the discounted cash flow analysis.
Market cap | $361.77 Million |
---|---|
Enterprise Value | $272.78 Million |
Dividend Yield | $0 (0%) |
Earnings per Share | $1.06 |
Beta | 0.68 |
Outstanding Shares | 22,873,800 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 12.91 |
---|---|
PEG | 23.4 |
Price to Sales | 1.56 |
Price to Book Ratio | 0.92 |
Enterprise Value to Revenue | 1.15 |
Enterprise Value to EBIT | 74.35 |
Enterprise Value to Net Income | 19 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0 |
No data
No data